Loading...
•
Jun 30, 2021
MannKind Q2 2021 Earnings Report
Achieved revenue growth driven by Afrezza and collaboration revenue.
Key Takeaways
MannKind Corporation reported a net loss of $35.5 million, or $0.14 per share, for the second quarter of 2021. Total revenues were $23.3 million, a 54% increase compared to the second quarter of 2020, driven by Afrezza net revenue of $10.0 million and collaboration and services revenue of $13.3 million. The company had $201.4 million in cash, cash equivalents and investments as of June 30, 2021.
Total revenues increased by 54% to $23.3 million compared to Q2 2020.
Afrezza net revenue increased by 43% to $10.0 million compared to Q2 2020.
Collaboration and services revenue increased by 64% to $13.3 million compared to Q2 2020, primarily due to the collaboration with United Therapeutics.
The company had $201.4 million of cash, cash equivalents and investments at the end of the quarter.
Revenue by Segment
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...